Share
3,618 Posts.
lightbulb Created with Sketch. 59
clock Created with Sketch.
04/04/18
11:04
Share
Originally posted by supercendol
↑
Hi all,
Thank you for your kind words.
Additional info I gathered yesterday + my opinion:
There was a potential investor who went there for Acrux (ACR) presentation but became attracted to Imugene because of its potential. He tried to place a dollar value on IMU SP, which was not unlike us, Few Pennies for example. Interestingly, but probably not significant, Leslie responded that she thought Imugene has the potential to reach $1. I can't recall whether she said this 'before she joined' or 'after she joined'.
Anyway, just like any other pennystock investment, there's always a significant risk - market doesn't tolerate failure & will punish severely, sometimes beyond the fundamental value of the company. The contrast between ACR & IMU current SP opened my eyes about this. ACR has a cash reserve of $32m but an MC of only $25m. On the other hand IMU with $11m but $100m MC.
The presenter of ACR presentation, Michael Kotsanis, said this was due to recent termination of a licensing agreement with their big pharma partner, Eli Lilly. Michael tried to promote ACR pipelines & potentials so it's difficult for him to explain how it's possible for a company to have an MC lower than the cash reserve. Maybe it's a good buying opportunities? But I'm really not into pennystock except IMU.
So, we have a massive potential on one hand if IMU is successful & a big fall on the other for undesirable results. Remember to always be responsible on your investment (I really should say this to myself everyday, shouldn't I?).
Take care!
Expand
$1 or $2.8 (say 3) Billion dollar company. Stop it super or I'll have to post another purple eggplant.